SSMD Agrotech India IPO GMP Today – Latest Updates & Market Sentiment | Finowings
Explore SSMD Agrotech India IPO details including GMP or grey market premium, price, date, listing date, allotment date & status with company financials
Shivam.Finowings 
The SSMD Agrotech India IPO GMP today continues to attract heightened interest from SME IPO investors as the company’s public issue enters its final subscription phase. With a fresh issue of ₹34.09 crore comprising 28 lakh newly issued shares, the company aims to strengthen its operational capabilities, enhance working capital, and support future expansion plans within the agrotech sector.
The IPO opened for subscription on November 25, 2025, and will remain active until November 27, 2025. Investors are now closely watching the demand across retail and HNI categories as the subscription momentum increases. The basis of allotment is expected on November 28, 2025, and the IPO is scheduled to list on BSE SME with a tentative listing date of December 2, 2025.
SSMD Agrotech India has fixed its price band at ₹114–₹121 per share.
For retail investors, the minimum lot size is 1,000 shares, resulting in a required investment of ₹2,42,000 at the upper band.
HNI investors must apply for at least 3 lots (3,000 shares), amounting to ₹3,63,000.
As subscription numbers rise, the SSMD Agrotech India IPO GMP is gaining more visibility in the grey market. Investors often track GMP trends to estimate potential listing-day performance. While GMP is not an official metric, it does act as an early sentiment indicator, reflecting the market’s confidence in the company’s business model, sector outlook, and issue valuation.
With SME IPOs showing strong traction and investor appetite improving week by week, SSMD Agrotech India is emerging as a notable IPO to watch. The company’s focus on agrotech solutions, operational expansion, and future-ready strategies have positioned it as a promising contender in the current SME pipeline.
Stay tuned with Finowings for real-time updates on SSMD Agrotech India IPO GMP, subscription status, investor response, and expected listing outcomes.
